Lakefront Biotherapeutics (LKFT)
29.73
+0.22
(+0.75%)
USD |
NASDAQ |
Oct 09, 16:00
29.74
+0.02
(+0.05%)
After-Hours: 20:00
Lakefront Biotherapeutics Total Assets (Quarterly) : 3.831B for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.831B |
| March 31, 2026 | 3.886B |
| December 31, 2025 | 4.001B |
| September 30, 2025 | 4.126B |
| June 30, 2025 | 4.482B |
| March 31, 2025 | 4.345B |
| December 31, 2024 | 4.283B |
| September 30, 2024 | 4.656B |
| June 30, 2024 | 4.598B |
| March 31, 2024 | 4.710B |
| December 31, 2023 | |
| September 30, 2023 | 4.713B |
| June 30, 2023 | 4.934B |
| March 31, 2023 | 5.033B |
| December 31, 2022 | 5.053B |
| September 30, 2022 | 4.871B |
| June 30, 2022 | 5.269B |
| March 31, 2022 | 5.675B |
| December 31, 2021 | 5.906B |
| September 30, 2021 | 6.180B |
| June 30, 2021 | 6.440B |
| March 31, 2021 | 6.599B |
| December 31, 2020 | 6.996B |
| September 30, 2020 | 6.709B |
| June 30, 2020 | 6.572B |
| Date | Value |
|---|---|
| March 31, 2020 | 6.575B |
| December 31, 2019 | 6.812B |
| September 30, 2019 | 6.380B |
| June 30, 2019 | 1.546B |
| March 31, 2019 | 1.572B |
| December 31, 2018 | 1.646B |
| September 30, 2018 | 1.725B |
| June 30, 2018 | 1.406B |
| March 31, 2018 | 1.513B |
| December 31, 2017 | 1.545B |
| September 30, 2017 | 1.574B |
| June 30, 2017 | 1.561B |
| March 31, 2017 | 1.147B |
| December 31, 2016 | 1.143B |
| September 30, 2016 | 1.172B |
| June 30, 2016 | 1.185B |
| March 31, 2016 | 1.230B |
| December 31, 2015 | 480.70M |
| September 30, 2015 | 514.65M |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 49.36B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alkermes Plc | 4.393B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Amarin Corp. Plc | 624.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 100.11M |
| Shareholders Equity (Quarterly) | 3.731B |
| Debt to Equity Ratio | 0.0019 |
| Current Ratio | 32.82 |
| Net Debt Paydown Yield | 0.05% |